Table 3. Studies reporting on various measures of lymphedema-related morbidity.
Outcome measure | No. of studies | References |
---|---|---|
Change in ADLA incidence | 13 | [13, 16–18, 26, 27, 29, 30, 32, 34, 35, 40, 42] |
Change in patients reporting at least one ADLA attack/time period | 8 | [13, 28, 29, 31, 33, 34, 36, 37] |
Change in reported quality of life measure * | 5 | [14, 33, 38–40] |
Change in stage or grade of affected limb | 4 | [32, 37, 39, 41] |
Change in leg volume | 3 | [26, 33, 34] |
Change in limb circumference | 2 | [34] |
Change in duration of acute attack | 2 | [28, 37] |
Change in histology of skin punch biopsy | 1 | [41] |
Change in days lost of work | 1 | [13] |
*Defined and measured in various ways across studies, including perceived quality of life, disability, and depression.